-
A NOVEL APPROACH- COLLABORATION BETWEEN SPEECH THERAPISTS, CLINICIANS, AND TRANSLATION TEAMS TO GENERATE GLOBAL ASSESSMENTS FOR STROKE PATIENTS
Mar 18, 2026, 21:38 PM -
EVOLUTION OF FDA COMPANION DIAGNOSTICS
Mar 18, 2026, 21:38 PM -
IMPACT OF TELEMEDICINE ENCOUNTERS ON SURVIVAL OUTCOMES: A TIME-VARYING COX ANALYSIS USING EHR-DERIVED DATA
Mar 18, 2026, 21:38 PM -
HEALTHCARE RESOURCE UTILIZATION AND COSTS OF DIABETES MELLITUS: A RETROSPECTIVE REAL-WORLD COST-OF-ILLNESS ANALYSIS IN BRAZIL
Mar 18, 2026, 21:38 PM -
COMPARING HEALTH OUTCOMES BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) STATUS AND RISK LEVEL: FINDINGS FROM THE US NATIONAL HEALTH AND WELLNESS SURVEY
Mar 18, 2026, 21:38 PM -
COST EFFECTIVENESS OF FIRSEKIBART FOR THE TREATMENT OF ACUTE GOUT PATIENTS UNSUITABLE FOR STANDARD THERAPY IN CHINA
Mar 18, 2026, 21:38 PM -
BRIDGING EVIDENCE AND ACCESS: SURVEY-BASED INSIGHTS INTO HOW BIOPHARMACEUTICAL MANUFACTURERS DEVELOP AND SHARE HCEI RESOURCES
Mar 18, 2026, 21:38 PM -
EVALUATING THE IMPACT OF THE INFLATION REDUCTION ACT OUT-OF-POCKET CAPS ON PATIENT ASSISTANCE FUNDS EFFICIENCY AND COVERAGE EXPANSION
Mar 18, 2026, 21:38 PM -
MIND THE GAP:EVALUATION OF ARTIFICIAL INTELLIGENCE (AI) ASSISTED EVIDENCE GAP ANALYSIS APPROACHES FOR PCSK-9 INHIBITORS
Mar 18, 2026, 21:38 PM -
COST OF CARE AND BUDGET IMPACT OF NOVEL FIRST-LINE (1L) TREATMENTS IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA (LA/MUC) IN COSTA RICA
Mar 18, 2026, 21:38 PM -
THE VALUE VOCABULARY: AN ANALYSIS OF SOCIETAL TERMS IN CDA-AMC AND INESSS HEALTH TECHNOLOGY ASSESSMENT DECISION MAKING
Mar 18, 2026, 21:38 PM -
LEVERAGING THE 2022 INFECTION PREVENTION AND CONTROL RESPONSE STRATEGY TO CONTROL THE 2025 SUDAN VIRUS DISEASE OUTBREAK IN EASTERN UGANDA
Mar 18, 2026, 21:38 PM -
ASSOCIATION BETWEEN TELEHEALTH-DELIVERED NUTRITION THERAPY AND RISK OF NEW-ONSET OBESITY IN ADULTS WITH TYPE 2 DIABETES: A PROPENSITY SCORE-MATCHED SURVIVAL ANALYSIS
Mar 18, 2026, 21:38 PM -
SOCIAL AND DEMOGRAPHIC DETERMINANTS OF DISEASE BURDEN AMONG ADULTS WITH SPINAL MUSCULAR ATROPHY
Mar 18, 2026, 21:38 PM -
COST IMPLICATIONS OF BRCA TESTING: CHANGES IN HEALTHCARE UTILIZATION AND EXPENDITURES FOLLOWING A NATIONAL SCREENING CAMPAIGN
Mar 18, 2026, 21:38 PM -
INCORPORATING SPILLOVER EFFECTS IN COST-EFFECTIVENESS ANALYSIS: A CASE STUDY FOR FIRST LINE TREATMENT OF METASTATIC (STAGE IV) NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC)
Mar 18, 2026, 21:38 PM -
PATIENT EXPERIENCE DOSSIERS IN PRACTICE: A DEMONSTRATION PROJECT IN METASTATIC NON-SMALL CELL LUNG CANCER
Mar 18, 2026, 21:38 PM -
REAL-WORLD TRENDS AND PAYER DIFFERENCES IN BUPRENORPHINE DISPENSING AMONG ADOLESCENTS AND YOUNG ADULTS (AYA) WITH OPIOID USE DISORDER (OUD)
Mar 18, 2026, 21:38 PM -
POST-PANDEMIC BURDEN OF COVID-19 AMONG HIGH-RISK PATIENTS WITH ACUTE INFECTION: A CROSS-SECTIONAL SURVEY IN GERMANY
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF LAZERTINIB-AMIVANTAMAB COMPARED TO OSIMERTINIB FOR NON-SMALL CELL LUNG CANCER: A 5-YEAR PARTITIONED SURVIVAL MODEL
Mar 18, 2026, 21:38 PM
